Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary

Kim, H., & Kolaski, K. (2021). Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary. NeuroRehabilitation, 49(1), 161–164. https://doi.org/10.3233/nre-218003
Authors:
Heakyung Kim
Kat Kolaski
Affiliated Authors:
Heakyung Kim
Columbia Affiliation:
Subjects:
Botulinum Toxins, Type A (MeSH)
Cerebral Palsy (MeSH)
Neuromuscular Agents (MeSH)
Author Keywords:
botulinum toxin a
efficacy
evidence
safety
spasticity
elink
Publication Type:
Article
Unique ID:
10.3233/nre-218003
PMID:
34366300
DOI:
10.3233/nre-218003
Journal:
Neurorehabilitation
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: